About this trial
The aim of this study is to compare the efficacy of nebulized ketamine versus nebulized magnesium sulfate in reducing the incidence and severity of POST.
* Primary outcome
• To compare the incidence of POST method. * Secondary outcomes
* Onset, Severity, and duration of POST at 0, 2, 4, 6, 12, 24 hours postoperative. * The hemodynamics recording (HR, BP, MBP, pre and post nebulization) * Adverse Effects (e.g., sedation, cough, nausea, vomiting, ….)
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age from 18 to 65 years old.
Both sexes.
American Society of Anesthesiologists (ASA) physical status I-II.
Elective surgery requiring GA with endotracheal intubation.
Disqualifiers
Surgery involves the oral cavity, nasopharynx, larynx, and neck regions.
Surgery requires prone position.
Surgery lasted more than 3 hours.
History of preoperative sore throat, common cold.
Trial design
Parallel
Treatments tested in this trial
Ketamine nebulizer
Drug50 patients will receive preoperative nebulization with 50 mg ketamine in 5 ml normal saline.
Mg sulfate nebulizer
Drug50 patients will receive preoperative nebulization with 250 mg magnesium sulfate in 5 ml normal saline.
Placebo
Drug50 patients will receive preoperative nebulization with 5 ml normal saline.
Treatment groups
Trial outcomes
Primary outcomes
To compare the incidence of Post operative sore throat method.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: